
|Articles|October 1, 2003
PSORIASIS TX MINUS SIDE EFFECTS
A new drug, Onercept or r-hTBP-1, seems promising in the treatment of psoriasis.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Day 1 Recap: Elevate-Derm Fall Conference
5



















